| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Total Liabilities Shareholders' Equity | 3,982.90 | 3,411.45 | 2,850.41 | 2,702.15 |
| Cash Equivalents | 0.00 | 25.02 | 269.60 | 228.06 |
| Other Liabilities Total | 36.15 | 18.54 | 15.77 | 7.87 |
| Accrued Expenses | 58.18 | 34.28 | 28.43 | 8.38 |
| Common Stock Total | 24.55 | 24.51 | 24.51 | 24.51 |
| Other Current Assets Total | 0.25 | 0.30 | 0.70 | 26.22 |
| Prepaid Expenses | 6.31 | 2.26 | 0.81 | 0.14 |
| Total Assets | 3,982.90 | 3,411.45 | 2,850.41 | 2,702.15 |
| Current Portof LT Debt/ Capital Leases | 7.98 | 5.65 | 2.39 | 2.26 |
| Additional Paid- In Capital | 1,018.79 | 1,005.72 | 1,004.96 | 1,004.96 |
| Cash | 1.98 | 46.04 | 31.82 | 55.76 |
| Total Equity | 3,332.13 | 2,817.37 | 2,332.32 | 2,138.21 |
| Long Term Investments | 0.08 | 0.08 | 0.08 | 0.08 |
| Retained Earnings( Accumulated Deficit) | 2,288.79 | 1,787.15 | 1,302.86 | 1,108.75 |
| Total Common Shares Outstanding | 12.27 | 12.25 | 12.25 | 12.25 |
| Tangible Book Valueper Share Common Eq | 269.05 | 228.31 | 189.14 | 173.04 |
| Total Liabilities | 650.77 | 594.08 | 518.09 | 563.94 |
| Total Debt | 56.77 | 56.61 | 17.15 | 19.36 |
| Short Term Investments | 780.38 | 477.61 | - | - |
| Cashand Short Term Investments | 782.36 | 548.68 | 301.41 | 283.82 |
| Total Receivables Net | 1,154.88 | 1,101.72 | 931.95 | 918.31 |
| Notes Payable/ Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Income Tax | 57.79 | 54.43 | 48.79 | 42.43 |
| Accounts Receivable- Trade Net | 1,072.96 | 969.74 | 765.43 | 806.77 |
| Property/ Plant/ Equipment Total- Net | 1,291.38 | 1,036.92 | 896.20 | 824.24 |
| Total Current Liabilities | 508.04 | 470.16 | 438.77 | 496.54 |
| Total Inventory | 705.56 | 682.20 | 681.13 | 621.86 |
| Accounts Payable | 372.37 | 390.46 | 368.66 | 427.23 |
| Other Currentliabilities Total | 69.51 | 39.77 | 39.30 | 58.68 |
| Total Long Term Debt | 48.79 | 50.96 | 14.76 | 17.09 |
| Intangibles Net | 29.93 | 19.94 | 14.85 | 18.00 |
| Other Long Term Assets Total | 6.72 | 6.37 | 11.03 | 8.21 |
| Note Receivable- Long Term | 5.44 | 12.99 | 12.26 | 1.27 |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 2,649.36 | 2,335.16 | 1,916.00 | 1,850.34 |
| Capital Lease Obligations | 48.79 | 50.96 | 14.76 | 17.09 |
| Accumulated Depreciation Total | - | -253.73 | -199.36 | -151.62 |
| Property/ Plant/ Equipment Total- Gross | - | 1,196.40 | 994.37 | 926.51 |
Alivus Life Sciences Dividend Alivus Life Sciences Bonus Alivus Life Sciences News Alivus Life Sciences AGM Alivus Life Sciences Rights Alivus Life Sciences Splits Alivus Life Sciences Board Meetings Alivus Life Sciences Key Metrics Alivus Life Sciences Shareholdings Alivus Life Sciences Profit Loss Alivus Life Sciences Cashflow Alivus Life Sciences Q1 Results Alivus Life Sciences Q2 Results Alivus Life Sciences Q3 Results Alivus Life Sciences Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.